{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T10:15:18Z","timestamp":1694859318810},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The present study was performed to statistically explore the effect of anthrax toxin receptor 2 (ANTXR2) polymorphism rs4333130 on individual susceptibility to ankylosing spondylitis (AS) using the method of meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All of the eligible reports were retrieved from well-known electronic databases. The strength of the association between <jats:italic toggle=\"yes\">ANTXR2<\/jats:italic> polymorphism rs4333130 and the susceptibility to AS was evaluated using pooled odds ratios (ORs) with 95% confidence intervals (95% CIs). In addition, subgroup analysis was also performed on the basis of ethnicity to further explore specific correlation between our studied polymorphism and the disease risk. Inter-study heterogeneity was detected with <jats:italic toggle=\"yes\">Q<\/jats:italic> test, and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05 was considered statistically significant. Sensitivity analysis was implemented through removing each of eligible studies and then recalculating overall effects to test the reliability of final estimates. Publication bias among included studies was inspected with both Begg funnel plot and Egger regression test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 6 eligible papers were finally incorporated into the present meta-analysis. In total analysis, <jats:italic toggle=\"yes\">ANTXR2<\/jats:italic> polymorphism rs4333130 was significantly related to decreased risk of AS under CC versus TT, CC\u200a+\u200aTC versus TT, CC versus TT\u200a+\u200aTC, C versus T and TC versus TT contrasts (OR\u200a=\u200a0.35, 95% CI\u200a=\u200a0.20\u20130.64; OR\u200a=\u200a0.81, 95% CI\u200a=\u200a0.69\u20130.95; OR\u200a=\u200a0.38, 95% CI\u200a=\u200a0.21\u20130.68; OR\u200a=\u200a0.89, 95% CI\u200a=\u200a0.84\u20130.95; OR\u200a=\u200a0.84, 95% CI\u200a=\u200a0.72\u20130.99). Moreover, a similar effect was also observed in Asian and Caucasian subgroups under corresponding genetic models after stratification analysis based on ethnicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">ANTXR2<\/jats:italic> polymorphism rs4333130 may function as a protective factor against AS incidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019942","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T09:03:41Z","timestamp":1594285421000},"page":"e19942","source":"Crossref","is-referenced-by-count":0,"title":["Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis"],"prefix":"10.1097","volume":"99","author":[{"given":"Haitao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/postgradmedj-2017-134964","article-title":"Association between the autophagy-related gene ULK1 and ankylosing spondylitis susceptibility in the Chinese Han population: a case-control study","volume":"93","author":"Zhang","year":"2017","journal-title":"Postgrad Med J"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/03009742.2016.1152399","article-title":"Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis","volume":"45","author":"Gamez-Nava","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"e009661","DOI":"10.1136\/bmjopen-2015-009661","article-title":"Biologic treatment registry across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis","volume":"6","author":"Rahman","year":"2016","journal-title":"BMJ Open"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0269215513512214","article-title":"Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up","volume":"28","author":"Masiero","year":"2014","journal-title":"Clin Rehabil"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10067-015-3056-1","article-title":"Construct validity of clinical spinal mobility tests in ankylosing spondylitis: a systematic review and meta-analysis","volume":"35","author":"Castro","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","article-title":"Genetics of ankylosing spondylitis--insights into pathogenesis","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00296-012-2510-5","article-title":"Health-related quality of life in Turkish patients with ankylosing spondylitis: impact of peripheral involvement on quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning","volume":"33","author":"Yilmaz","year":"2013","journal-title":"Rheumatol Int"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10067-015-2956-4","article-title":"Ankylosis in ankylosing spondylitis: current concepts","volume":"34","author":"Haroon","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.160347","article-title":"Developing a risk-scoring model for ankylosing spondylitis based on a combination of HLA-B27, Single-nucleotide polymorphism, and copy number variant markers","volume":"43","author":"Jung","year":"2016","journal-title":"J Rheumatol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/toxins8070197","article-title":"Tumor targeting and drug delivery by anthrax toxin","volume":"8","author":"Bachran","year":"2016","journal-title":"Toxins"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M116.753301","article-title":"Anthrax toxin protective antigen variants that selectively utilize either the CMG2 or TEM8 receptors for cellular uptake and tumor targeting","volume":"291","author":"Chen","year":"2016","journal-title":"J Biol Chem"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1074\/jbc.M113.538587","article-title":"Targeted silencing of anthrax toxin receptors protects against anthrax toxins","volume":"289","author":"Arevalo","year":"2014","journal-title":"J Biol Chem"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2741\/3806","article-title":"Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy","volume":"16","author":"Cryan","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"15861","DOI":"10.1038\/ncomms15861","article-title":"CMG2\/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome","volume":"8","author":"Burgi","year":"2017","journal-title":"Nat Commun"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci","volume":"42","author":"Reveille","year":"2010","journal-title":"Nat Genet"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.100652","article-title":"Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patients","volume":"38","author":"Bang","year":"2011","journal-title":"J Rheumatol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00296-010-1566-3","article-title":"ANTXR2 and IL-1R2 polymorphisms are not associated with ankylosing spondylitis in Chinese Han population","volume":"32","author":"Chen","year":"2012","journal-title":"Rheumatol Int"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009742.2011.600700","article-title":"Association of the ANTXR2 gene polymorphism and ankylosing spondylitis in Chinese Han","volume":"41","author":"Guo","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1136\/annrheumdis-2014-205643","article-title":"Ankylosing spondylitis is associated with the anthrax toxin receptor 2 gene (ANTXR2)","volume":"73","author":"Karaderi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-015-3391-1","article-title":"Determination of IL1 R2, ANTXR2, CARD9, and SNAPC4 single nucleotide polymorphisms in Iranian patients with ankylosing spondylitis","volume":"36","author":"Momenzadeh","year":"2016","journal-title":"Rheumatol Int"},{"key":"R23-20230915","article-title":"Relationship Between HLA-B27 Polymorphism, Non-MHC Gene Polymorphism and Ankylosing Spondylitis[D]","author":"Zhang","year":"2012","journal-title":"Anhui Medical University"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/mmr.2017.6248","article-title":"Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (review)","volume":"15","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1038\/ncomms8146","article-title":"Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1","volume":"6","author":"Cortes","year":"2015","journal-title":"Nat Commun"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5808\/GI.2017.15.2.65","article-title":"A variant in RUNX3 is associated with the risk of ankylosing spondylitis in Koreans","volume":"15","author":"Cho","year":"2017","journal-title":"Genomics Inform"},{"key":"R27-20230915","first-page":"7679","article-title":"Anthrax toxin receptor 2 gene (ANTXR2) rs4333130 is associated with ankylosing spondylitis","volume":"8","author":"Ou","year":"2015","journal-title":"Int J Clin Exp Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:35:59Z","timestamp":1694828159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":27,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019942","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]}}}